| BioID | bio3075 |
| Name | REVEFENACIN |
| ChEMBL ID | CHEMBL3833319 |
| Molecular Formula | C35H43N5O4 |
| Molecular Weight | 597.76 |
| Molecular Weight (Monoisotopic) | 597.3315 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar12 |
| Target Name | Toll-like receptor 9 (TLR9) |
| Synonyms | GSK-1160724|GSK1160724|REVEFENACIN|REVEFENACINA|REVEFENACINE|TD-4208|YUPELRI |
| Smiles | CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1 |
| Inchi | InChI=1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43) |
| Inchi Key | FYDWDCIFZSGNBU-UHFFFAOYSA-N |
| Molecular Species | BASE |
| Targets | 33.0 |
| Bioactivities | 66.0 |
| Np Likeness Score | -1.3 |
| Records Key | ['REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'Example-1', 'REVEFENACIN', 'EUB0000925a', 'EUB0000925a', 'EUB0000925a', 'EUB0000925a', 'EOS100079'] |
| Records Name | ['REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'Biphenyl-2-ylcarbamic Acid 1-(2-{[4-(4-Carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl Ester', 'REVEFENACIN', 'Revefenacin', 'Revefenacin', 'Revefenacin', 'Revefenacin', 'REVEFENACIN'] |
| Withdrawn Flag | False |
| Orphan | 0 |